製品名:5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-amine

IUPAC Name:5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-amine

CAS番号:1180132-17-5
分子式:C12H20N4
純度:95%
カタログ番号:CM169616
分子量:220.32

包装単位 有効在庫 価格(USD) 数量
CM169616-5g in stock ƴŪ
CM169616-10g in stock ǫȅ
CM169616-25g in stock ŸŸǫ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1180132-17-5
分子式:C12H20N4
融点:-
SMILESコード:CCN1CCN(CC2=CN=C(N)C=C2)CC1
密度:
カタログ番号:CM169616
分子量:220.32
沸点:362°C at 760 mmHg
MDL番号:MFCD14706690
保管方法:Keep in dark place, store at 2-8°C.

Category Infos

Piperazines
Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.
Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

Abemaciclib
Lilly announced the five-year results of a pre-planned analysis of Phase 3 MonarchE study, which evaluated two years of adjuvant Verzenio® (Abemaciclib) in combination with endocrine therapy (ET) compared with ET alone in patients with HR+, HER2-, node-positive early breast cancer (EBC) at a high risk of recurrence. Abemaciclib is the first and only CDK4/6 inhibitor approved for the treatment of node-positive, high-risk early breast cancer (EBC) patients.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products